ZENSUN ENT (00185.HK) announced its full-year results for the year ended last December, with a revenue of RMB 9.542 billion, a year-on-year decrease of 52.4%. The loss narrowed to RMB 2.182 billion, compared to a loss of RMB 2.298 billion in the same period last year; the loss per share was 114 cents. No dividend was declared